Choose Language
Select a language for news translation.
Tech workers' identities are collapsing after mass layoffs—over 240,000 tech jobs cut in 2023-24—revealing that company roles don’t define self-worth. Survivor…
Apple raised MacBook Air and MacBook Pro prices by $150–$200 due to surging memory costs, marking a shift in stable pricing. Competitors may follow, risking sl…
Colossal Biosciences will sequence the genomes of all 1,600 U.S. endangered species, creating a genetic database to aid conservation efforts like tracking inbr…
Australia’s highest-paid TV presenter, Kyle Sandilands, faces job loss after hosting far-right activist Tommy Robinson on his podcast, sparking advertiser back…
GLP-1 drugs like Ozempic and Wegovy help average 15% fat loss, but up to 30% see less than 5% weight loss after six months; poor sleep, medications, and geneti…
JPMorgan Chase will buy back up to $50 billion in shares and all major U.S. banks raised dividends after the Fed’s stress test showed they can withstand severe…
The Federal Reserve’s stress test shows U.S. banks could withstand $708 billion in losses from severe economic downturns, demonstrating stronger resilience tha…
Insurers are dropping coverage for weight-loss drugs like Zepbound and Wegovy due to high costs, leaving 24 million Americans without access by 2026. Coverage …
A new white paper from eight major EU-funded pollinator projects warns that the resilience of Europe's vital societal functions and food security are at stake …
What to do if your insurance denies your obesity drug.
The well-known trading bot took a hit this weekend after it fell victim to a series of transactions that left its logic exposed.
